PAMP
DICE

Polar Asset Management Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Polar Asset Management Partners’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-75,014
Closed -$1.9M – 1578
2021
Q4 		$1.9M Buy
+75,014
New +$2.2M 0.02% 618

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Polar Asset Management Partners's DICE Position: Q1 2022 in Review

Polar Asset Management Partners sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q1 2022, closing a stake of 75,014 shares — an estimated $1.9M sold.

Polar Asset Management Partners first reported a position in DICE in Q4 2021 and held it in 1 quarter. The position peaked at $1.9M in Q4 2021. 76 funds tracked by Wall St. Rank hold DICE as of Q1 2022.

  • Polar Asset Management Partners reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Polar Asset Management Partners sold 75,014 DICE Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $1.9M.
  • Polar Asset Management Partners first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Polar Asset Management Partners's DICE Therapeutics, Inc. Common Stock position peaked at $1.9M in Q4 2021.
  • 76 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Polar Asset Management Partners's 13F filing for Q1 2022, filed 16 May 2022.